Brief: Angion Says Receives Nasdaq Notice Regarding Minimum Bid Price Requirements
Dec 21 (Reuters) - Angion Biomedica Corp ANGN.O :
* ANGION RECEIVES NASDAQ NOTICE REGARDING MINIMUM BID PRICE
REQUIREMENTS
* ANGION BIOMEDICA- NOTIFIED BY NASDAQ LISTING
QUALIFICATIONS
STAFF THAT SINCE LAST 30 DAYS BID PRICE OF CO'S COMMON STOCK HAD
CLOSED BELOW $1.00/SHARE
Source text for Eikon: ID:nGNX8MN6vz
Further company coverage: ANGN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Elicio Therapeutics
See all newsFactbox: Moderna-Merck melanoma vaccine leads race for first therapeutic cancer vaccine
Elicio Therapeutics Q2 net loss narrows as R&D expenses fall
Elicio Therapeutics Inc expected to post a loss of 54 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Datadog, Terawulf, Paychex
Elicio shares slide after pancreatic cancer vaccine falls short in mid-stage study (updated)